Clinical Trials Update: July 2, 2009 (HealthDay) HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com: Glaucoma patients overrate their eyedrop skills (Reuters) Reuters - Although more than 90 percent of patients taking ocular medication reported feeling confident about their eyedrop instillation technique, less than one third actually demonstrated adequate skills, researchers report in the Archives of Ophthalmology. WHO chief identifies "warning signs" of severe flu (Reuters)
Clinical Trials Update: July 1, 2009 (HealthDay) HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch: FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer (HealthDay) HealthDay - WEDNESDAY, July 1 (HealthDay News) -- Despite recent studies suggesting that the injected diabetes drug Lantus (insulin glargine) might boost cancer risk, the U.S. Food and Drug Administration on Wednesday urged patients who are on the medication to continue using it. With Medicare Plan, Drug Spending May Be Up (HealthDay) HealthDay - WEDNESDAY, July 1 (HealthDay News) -- Older people who signed up for Medicare's prescription drug coverage, called Part D, spent more on drugs after enrolling than they had before but less on other types of medical care, researchers have found. WHO to start clinical trial on river blindness drug (AFP)
Clinical Trials Update: June 30, 2009 (HealthDay) HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com: U.S. panel urge stronger limits for some pain drugs (Reuters)
You can save this news page by submitting it to your favorite sites:
All News Lines - Local and World Wide, Updated Hourly
|


Reuters - H1N1 influenza is causing mild symptoms that go away without medication in most patients, but care-givers should be alert for warning signs of severe cases, the head of the World Health Organization said on Thursday.
AFP - The World Health Organisation said Wednesday it was launching a clinical trial for a drug that could halve the treatment period for river blindness, a disease that threatens 100 million people mostly in Africa.
Reuters - A U.S. advisory panel on Tuesday called for greater restrictions on the widely-used pain reliever acetaminophen, even recommending banning some medications that contain it, in a bid to prevent potentially fatal overdoses.